Symbol="AXSM"
AssetType="Common Stock"
Name="Axsome Therapeutics Inc"
Description="Axsome Therapeutics, Inc., a biopharmaceutical company, is dedicated to developing new therapies for central nervous system (CNS) disorders in the United States. The company is headquartered in New York, New York."
CIK="1579428"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="22 CORTLANDT STREET, 16TH FLOOR, NEW YORK, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="3313683000"
EBITDA="-159526384"
PERatio="None"
PEGRatio="0"
BookValue="5.97"
DividendPerShare="0"
DividendYield="0"
EPS="-3.81"
RevenuePerShareTTM="4.234"
ProfitMargin="-1.011"
OperatingMarginTTM="-0.888"
ReturnOnAssetsTTM="-0.256"
ReturnOnEquityTTM="-1.255"
RevenueTTM="182493000"
GrossProfitTTM="45939500"
DilutedEPSTTM="-3.81"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="4.295"
AnalystTargetPrice="116.45"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="134.76"
PriceToBookRatio="20.66"
EVToRevenue="121.47"
EVToEBITDA="-20.98"
Beta="1.878"
num_52WeekHigh="91.29"
num_52WeekLow="38.87"
num_50DayMovingAverage="75.78"
num_200DayMovingAverage="69.74"
SharesOutstanding="46573200"
DividendDate="None"
ExDividendDate="None"
symbol="AXSM"
open="68.50"
high="71.42"
low="68.26"
price="70.78"
volume="643829.00"
latest_trading_day="2023-08-18"
previous_close="69.25"
change="1.53"
change_percent="2.2094%"
aroon_positive_momentum_days="76"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="76"
Volume_recent_avg="868421"
Change_recent_avg="-0.03"
Delta_recent_avg="3.14"
Variance_recent_avg="1.57"
Change_ratio_recent_avg="-0.07"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="76"
Aroon_momentum_negative="24"
image_negative_thumbnail_id_1="1132"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0165.jpeg"
image_negative_thumbnail_id_2="132"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0044.jpeg"
image_neutral_thumbnail_id_1="590"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0009.jpeg"
image_neutral_thumbnail_id_2="550"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0049.jpeg"
image_positive_thumbnail_id_1="702"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0006.jpeg"
image_positive_thumbnail_id_2="1013"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0175.jpeg"
image_professor_thumbnail_id_1="1175"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0009.jpeg"
image_professor_thumbnail_id_2="1173"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
